
As soon as Friday, a district judge could issue a ruling potentially blocking the use of the abortion medication mifepristone across the United States.
The Alliance Defending Freedom (ADF) filed a lawsuit in November of 2022 against the U.S. Food and Drug Administration (FDA) on behalf of four national medical associations and several doctors, alleging that the agency “chose politics over science and approved chemical abortion drugs for use in the United States.”
“And it has continued to fail them by repeatedly removing even the most basic precautionary requirements associated with their use,” the complaint states.
For context, mifepristone is the first of two drugs used in a drug-induced abortion. According to former abortionist Dr. Anthony Levatino, mifepristone blocks the action of progesterone, which the mother’s body produces to nourish the pregnancy. When progesterone is blocked, the lining of the mother’s uterus deteriorates, and blood and nourishment are cut off to the developing baby, who then dies inside the mother’s womb. The drug misoprostol (also called Cytotec) then causes contractions and bleeding to expel the baby from the mother’s uterus.